We are live on
!
Find out more
Iovance Biotherapeutics
IOVA
IOVA
82 hedge funds and large institutions have $357M invested in Iovance Biotherapeutics in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 18 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
117% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 18
95% more capital invested
Capital invested by funds: $183M → $357M (+$174M)
56% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 9
6% more funds holding
Funds holding: 77 → 82 (+5)
91% less call options, than puts
Call options by funds: $841K | Put options by funds: $9.37M
Holders
82
Holders Change
+5
Holders Change %
+6.49%
% of All Funds
2.19%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.13%
New
14
Increased
39
Reduced
18
Closed
9
Calls
$841K
Puts
$9.37M
Net Calls
-$8.53M
Net Calls Change
-$11.1M
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$14.8M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
+$7.62M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$7.6M |
| 4 |
BC
Broadfin Capital
New York
|
+$6.69M |
| 5 |
PA
Perceptive Advisors
New York
|
+$5.18M |
